-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Acorda Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Acorda Therapeutics, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$19.6M, a 71% decline year-over-year.
- Acorda Therapeutics, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$273M, a 807% decline year-over-year.
- Acorda Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$265M, a 650% decline from 2022.
- Acorda Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$35.3M, a 55.3% increase from 2021.
- Acorda Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$79M, a 1.23% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)